- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04139161
Cycling Intervention on Symptoms of Patients With Knee Osteoarthritis
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The knee joint is one of the most common joints affected by osteoarthritis, and knee osteoarthritis is primarily observed in the medial compartment. This is in part attributable to the increased load experienced by the medial compartment during level walking. Patients with symptomatic knee osteoarthritis exhibit altered gait mechanics; namely a reduced loading response knee extension moment and an increased internal knee abduction moment. As a surrogate measure for medial compartment joint loading, loading response knee abduction moment in level walking has been shown to increase with the severity of knee osteoarthritis.
Recent gait modification research has shown that increased step-width decreases peak Knee abduction moment for persons with knee osteoarthritis. The inter-pedal width of a bicycle or cycle ergometer, known as Q-Factor, is analogous in cycling to step-width in gait. In contrast to gait, increased Q-Factor has been shown to increase the knee abduction moment during stationary cycling. Modulating sagittal and frontal plane loading of the knee in a graded manner during cycling may promote healthy adaptation to muscle weakness and pain. This adaptation may be manifest through restoration of altered knee joint biomechanics (knee extension moment, knee abduction moment), which, in turn, may also provide benefit to gait mechanics.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Tennessee
-
Knoxville, Tennessee, United States, 37996
- Recruiting
- Biomechanics/Sports Medicine Lab
-
Contact:
- Songning Zhang, PhD
- Phone Number: 865-974-4716
- Email: szhang@utk.edu
-
Contact:
- Tanner ThorsenZhang, MS
- Phone Number: 865-974-2091
- Email: tthorsen@vols.utk.edu
-
Principal Investigator:
- Tanner Thorsen, MS
-
Principal Investigator:
- Songning Zhang, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Men and Women between the ages of 50 and 75 years old.
- Diagnosed with medial compartment tibiofemoral osteoarthritis in one of their knees.
- Be able to walk unaided for at least 25 consecutive minutes.
- Present with knee pain for at least 6 months occurring on a majority of the days in the month, or on most days (more than or equal to 4 of 7 days in a week) in one or both knees for at least 4 months.
- Osteophytes on knee x-rays.
- Grade 2 or higher out of a maximum of 4 on a modified Kellgren/Lawrence grade on the knee radiograph.
Exclusion Criteria:
- Initial Visual Analog Scale pain scores greater than 7.
- Diagnosed osteoarthritis of ankles, hips, or symptomatic osteoarthritis of the spine.
- Arthroplasty of any other lower extremity joint.
- BMI value greater than 40 kg/m2.
- Any major lower extremity injury in the past 6 months.
- Systemic Inflammatory Arthritis.
- Systemic Pain Conditions.
- Neurological Conditions that impact gait or cycling.
- Pregnant or Nursing Women.
- Major cardiovascular disease with an exercise limitation prescribed by a physician.
- Steroid injection at the knee within the previous 3 months.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Q-Factor Intervention
Participants will progress through three increasing Q-Factors for each cycling workrate; Q-Factor 1 (Q1, 192mm), Q2 (234mm), Q3 (276mm).
After completing bouts of all three Q-Factors for a given workrate, workrate will be increased by 20 Watts and bouts at each Q-Factor will be repeated.
|
The intervention period will consist of 12 training sessions across four consecutive weeks, with three training sessions held per week.
If pain is not increased or reduced and Rating of Perceived Exertion is ≤12, the participant will progress to the next bout.
If pain is increased from the pre-bout pain score, participants will repeat the bout, at the same workrate and Q-Factor settings.
Following this fashion, participants will progress through three increasing Q-Factors for each given workrate; Q-Factor 1 (Q1, 192mm), Q2 (234mm), Q3 (276mm).
After completing bouts of all three Q-Factors for a given workrate, workrate will be increased by 20 Watts and bouts at each Q-Factor will be repeated.
For each training session, participants will complete bouts of cycling until 1) the maximum number of bouts (4 bouts) has been accomplished, 2) self-reported Rating of Perceived Exertion >12, indicating a transition to moderate physical activity, or 3) self-reported pain >5.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Knee Abduction Moment - Cycling
Time Frame: Baseline, 1 month, 2 month
|
Change in Knee Extension Moment during cycling.
|
Baseline, 1 month, 2 month
|
|
Knee Abduction Moment - Gait
Time Frame: Baseline, 1 month, 2 month
|
Change in Knee Extension Moment during gait.
|
Baseline, 1 month, 2 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Visual Analog Pain
Time Frame: Immediately following exercise (walking and cycling).
|
Self-Reported pain intensity during gait and cycling reported on a scale from 1-10 with higher scores reflecting more pain.
|
Immediately following exercise (walking and cycling).
|
|
Knee Extension Moment - Cycling
Time Frame: Baseline, 1 month, 2 month
|
Change in Knee Extension Moment during cycling
|
Baseline, 1 month, 2 month
|
|
Knee Extension Moment - Gait
Time Frame: Baseline, 1 month, 2 month
|
Change in Knee Extension Moment during Gait
|
Baseline, 1 month, 2 month
|
|
Knee Injury and Osteoarthritis Outcome Score
Time Frame: Baseline, 1 month, 2 month
|
Change in Knee Injury and Osteoarthritis Outcome Score reported on a scale from 0 to 100, with 0 representing extreme problems and 100 representing no problems.
|
Baseline, 1 month, 2 month
|
Collaborators and Investigators
Investigators
- Principal Investigator: Tanner Thorsen, MS, University of Tennessee, Knoxville
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- UTK IRB-19-05254-XP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Knee
-
Istanbul University - CerrahpasaCompletedKnee Osteoarthritis | Knee Osteoarthritis (Knee OA)Turkey (Türkiye)
-
Edin MešanovićCompletedOsteoarthritis | Osteoarthritis of the Knee | Osteoarthritis of Knee | Osteoarthritis of the Knees | Osteoarthritis (OA) of the Knee | Osteoarthritis Knee | Osteoarthritis in the Knee | Osteoarthritis of Knee JointBosnia and Herzegovina
-
Golden Jubilee National HospitalJohnson & Johnson; DePuy OrthopaedicsNot yet recruitingOsteoarthritis | Knee Osteoarthritis | Osteoarthritis (OA) | Osteo Arthritis | Osteoarthritis in the Knee | Osteoarthritis (Knee) | Osteo Arthritis of the KneeUnited Kingdom
-
Dr. David WassersteinSunnybrook Research InstituteRecruitingKnee Osteoarthritis (Knee OA) | Knee Osteoarthritis (OA)Canada
-
LifeBridge HealthMicroPort Orthopedics Inc.; Rubin Institute for Advanced OrthopedicsRecruitingKnee Osteoarthritis | Osteoarthritis, Knee | Knee Pain Chronic | Arthropathy of Knee Joint | Knee Disease | Osteoarthritis Knees Both | Osteoarthritis Knee Left | Osteoarthritis Knee RightUnited States
-
Lucas R. Cusumano, MDNot yet recruitingKnee Osteoarthritis | Knee Discomfort | Knee Pain Chronic | Knee Swelling PainUnited States
-
I.M. Sechenov First Moscow State Medical UniversityRecruitingKnee Osteoarthritis | Knee Osteoarthritis in VarusRussia
-
VA Office of Research and DevelopmentNot yet recruitingKnee Osteoarthritis (Knee OA)United States
-
The Hong Kong Polytechnic UniversityChinese University of Hong Kong; Zhujiang HospitalNot yet recruitingKnee Osteoarthritis (Knee OA)
-
University of MiamiNot yet recruiting
Clinical Trials on Q-Factor Intervention
-
Kenneth PalmerUnited States Department of DefenseRecruitingCOVID-19 PreventionUnited States
-
Wenzhou Medical UniversityStaar Surgical CompanyUnknown
-
Spaulding Rehabilitation HospitalRecruiting
-
Terry L. WahlsRecruitingMultiple Sclerosis | Clinically Isolated Syndrome | Fibromyalgia | Post Acute Sequelae of COVID-19 | Cancer in Remission With Persisting FatigueUnited States
-
Holland Bloorview Kids Rehabilitation HospitalCompleted
-
U.S. Army Medical Research and Development CommandUS Army Medical Research Institute of Infectious DiseasesWithdrawn
-
GlaxoSmithKlineCompleted
-
Sykehuset Asker og BaerumUniversity of OsloCompletedStroke | Cognitive Impairment | Vascular DementiaNorway
-
Cynosure, Inc.Terminated